Skip to main content
Log in

Concurrent allopurinol and 5-fluorouracil: 5-fluoro-2′-deoxyuridylate formation and thymidylate synthase inhibition in rat colon carcinoma and in regenerating rat liver

  • Original Articles
  • 5-FU, Allopurinol, Thymidylate Synthase, Colon Carcinoma
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

The formation of FdUMP and the inhibition of TS were studied in a subcutaneously growing transplantable rat colon carcinoma and in regenerating rat liver following bolus administration of 5-FU, with or without HPP pretreatment.

In tumor, peak levels of FdUMP at 30 min following bolus 5-FU, 100 mg/kg, averaged 4931±587 pmol/g. Pretreatment with HPP, 50 mg/kg, 24 h and 1 h before 5-FU, reduced the peak FdUMP level to 2085±387 pmol/g. The inhibition of TS by 5-FU treatment was greater than 95% by 30 min, and after 48 h residual enzyme inhibition averaged 40%. No effect on TS inhibition by 5-FU treatment could be observed as a result of HPP pretreatment. The levels of TStot increased linearly after 5-FU treatment and doubled within 48 h.

In regenerating rat liver, neither FdUMP levels nor TS inhibition, studied at 1 h after bolus 5-FU, were affected by HPP pretreatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

BSA:

bovine serum albumin

DMH:

dimethylhydrazine

5-FU:

5-fluorouracil

HPP:

allopurinol (4-hydroxypyrazolopyrimidine)

CH2FH4 :

5, 10-methylenepteroylmonoglutamic acid

FUMP:

5-fluorouridine-5′-monophosphate

FUTP:

5-fluorouridine-5′-triphosphate

FdUMP:

5-fluoro-2′-deoxyuridylate

TS:

thymidylate synthase (EC 2.1.1.45, dTMP synthase)

TSf :

free, non-FdUMP-bound TS

TSb :

ternary complex-bound TS

TStot :

total TS TSf+TSb

PRPP:

phosphoribosylpyrophosphate

References

  1. Barth O, Maass H (1970) Verhalten von Enzymaktivitäten, speziell der Thymidylate-Synthetase, nach Hepatectomie und deren Beeinflußbarkeit durch Trenimon und Aktinomycin. Z Krebstforsch 75: 45

    Google Scholar 

  2. Berger SH, Clark J, Kabus D, Berger G (1986) Thymidylate synthase, enzyme, mRNA and structural gene variation in human colonic cell lines and tumors. Proc AACR 27, March Abstr 1181

  3. Berne MHO, Gustavsson BG, Almersjö O, Spears CP (1986) Sequential methotrexate/5-FU:FdUMP formation and TS inhibition in a transplantable rodent colon adenocarcinoma. Cancer Chemother Pharmacol 16: 237

    Google Scholar 

  4. Berne MHO, Gustavsson B, Almersjö O, Spears CP, Waldenström J (1987) Thymidylate synthase inhibition by 5-fluorouracil in normal and regenerating rat liver. Cancer Lett (in press)

  5. Chabner B (1982) Pyrimidine antagonists. In: Pharmacological principles of cancer treatment. Saunders, Philadelphia, p 183

    Google Scholar 

  6. Clark PI, Slevin ML (1985) Allopurinol mouth washes and 5-fluorouracil induced toxicity. Eur J Surg Oncol 11: 267

    Google Scholar 

  7. Cory JG, Breland JC, Carter GC (1979) Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells. Cancer Res 39: 4905

    Google Scholar 

  8. Fox RM, Royse-Smith D, O'Sullivan WJ (1970) Orotinuria induced by allopurinol. Science 168: 861

    Google Scholar 

  9. Fox RM, Woods RL, Tattersal MHN, Piper AA, Sampsom D (1981) Allopurinol modulation of fluorouracil toxicity. Cancer Chemother Pharmacol 5: 511

    Google Scholar 

  10. Fyfe JA, Miller RL, Krenitsky TA (1973) Kinetic properties and inhibition of orotidine 5′phosphate decarboxylase. J Biol Chem 248: 3801

    Google Scholar 

  11. Higgins GM, Anderson RM (1931) Experimental pathology of the liver: restoration of the liver of the white rat following partial surgical removal. Arch Pathol 12: 186

    Google Scholar 

  12. Houghton JA, Houghton PJ (1980) 5-fluorouracil in combination with hypoxanthine and allopurinol: toxicity and metabolism in xenografts of human colonic carcinomas in mice. Biochem Pharmacol 29: 2077

    Google Scholar 

  13. Houghton JA, Houghton PJ (1983) elucidation of pathways of 5-fluorouracil metabolism in xenografts of human colorectal adenocarcinoma. Eur J Cancer Clin Oncol 19: 807

    Google Scholar 

  14. Houghton JA, Houghton PJ, Wooten RS (1979) Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine and 5-fluoro-2′-deoxyuridine. Cancer Res 39: 2406

    Google Scholar 

  15. Howell SB, Wung WE, Teatle R (1981) Modulation of 5-fluorouracil toxicity by allopurinol in man. Cancer 48: 1281

    Google Scholar 

  16. Kroener JF, Saleh F, Howell SD (1982) 5-FU and allopurinol: toxicity modulation and phase II results in colon cancer. Cancer Treat Rep 66: 1133

    Google Scholar 

  17. Kufe DW, Major PP (1981) 5-Fluorouracil incorporation into human breast carcinoma RNA correlates with cytotoxicity. J Biol Chem 256: 9802

    Google Scholar 

  18. Langenbach RI, Danenberg PV, Heidelberger C (1972) Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2′-deoxyuridylate. Biochem Biophys Res commun 48: 1565

    Google Scholar 

  19. Leissner KH, Gustavsson B (1984) Intravesical high dose 5-fluorouracil instillation combined with allopurinol — a therapeutic alternative in the treatment of multiple bladder tumors. J Urol 132: 34

    Google Scholar 

  20. Moran RG, Spears CP, Heidelberger C (1979) Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5′-fluoro-2′-deoxyuridylate, 2′-deoxyuridylate and thymidylate synthetase. Proc Natl Acad Sci 76: 1456

    Google Scholar 

  21. Myers CE (1981) The pharmacology of the fluoropyrimidines. Pharmacol Rev 33: 1

    Google Scholar 

  22. Nazar RN, Lawford HG, Wong JTF (1970) An improved procedure for extraction and analysis of cellular nucleotides. Anal Biochem 35: 305

    Google Scholar 

  23. Rustum Y, Schwartz H (1973) Methods for the separation and identification of ribonucleotides on DEAE-cellulose. Anal Biochem 53: 411

    Google Scholar 

  24. Santi DV, McHenry CS (1972) 5-Fluoro-2′-deoxyuridylate: covalent complex with thymidylate synthetase. Proc Natl Acad Sci USA 69: 1855

    Google Scholar 

  25. Schultz JD, Wilburn ME, Jackson EL et al. (1980) Differential effect of allopurinol (HPP) on incorporation of 5-fluorouracil (FU) into RNA of tumor and host cells isolated from CF1 mice bearing Ehrlich ascites tumor. Procc AACR 22: 270

    Google Scholar 

  26. Schwartz PM, Handschumacher RE (1979) Selective antagonism of 5-fluorouracil cytotoxicity by 4-hydroxypyrazolpyrimidine (allopurinol) in vitro. Cancer Res 39: 3095

    Google Scholar 

  27. Schwartz PM, Dunigan JM, Marsh JC, Handschumacher RE (1980) Allopurinol modification of the toxicity and antitumor activity of 5-fluorouracil. Cancer Res 40: 1885

    Google Scholar 

  28. Spears CP, Shahinian AH, Moran RG, Heidelberger C, Corbett TH (1982) In vivo kinetics of thymidylate synthetase inhibition in 5-fluorouracil-sensitive and-resistant murine adenocarcinomas. Cancer Res 42: 450

    Google Scholar 

  29. Spears P, Gustavsson B, Leissner KH, Danenberg P (1984) Parameters of thymidylate synthetase (TS) inhibition in bladder carcinoma after intravesical 5-fluorouracil (5-FU) combined with systemic allopurinol (abstract.) Proc AACR 25: 657

    Google Scholar 

  30. Spears CP, Shani J, Shainian AH, Wolf W, Heidelberger C, Dantenberg PV (1985) Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo. Mol Pharmacol 27: 302

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was supported by grants from the Swedish Cancer Society, The Medical Society of Göteborg, the University of Göteborg, the Wellcome Foundation, and NCI Grant 39629.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berne, M., Gustavsson, B., Almersjö, O. et al. Concurrent allopurinol and 5-fluorouracil: 5-fluoro-2′-deoxyuridylate formation and thymidylate synthase inhibition in rat colon carcinoma and in regenerating rat liver. Cancer Chemother. Pharmacol. 20, 193–197 (1987). https://doi.org/10.1007/BF00570483

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00570483

Keywords

Navigation